GE Healthcare Life Sciences strengthens business resilience with ISO 22301 business continuity accreditation for chromatography media

CHALFONT ST. GILES, UK – 3 December 2015 – GE Healthcare’s Life Sciences business today announced that its chromatography media manufacturing facility and supporting functions in Uppsala, Sweden have been certified to ISO 22301, the international standard for business continuity management systems.  Chromatography medium is a key component in the production of biopharmaceuticals such as... Read more

GE Healthcare and the National Basketball Association seek proposals to accelerate research on the prevention, diagnosis and treatment of tendinopathy

WAUKESHA, WI, and NEW YORK, NY – November 17, 2015 – GE Healthcare (NYSE: GE) and the National Basketball Association (NBA) today launched a call for research proposals for tendinopathy. The call for proposals is the first as part of a collaboration between the NBA and GE Healthcare to help research the prevention, diagnosis and... Read more

OHSU, GE Healthcare team up to explore new frontiers in health care innovation

PORTLAND, Ore. – Oregon Health & Science University and GE Healthcare have signed a memorandum of understanding to develop collaborative research programs in cardiovascular medicine, imaging and big data research. The research programs are aimed at bringing together OHSU’s clinical expertise with GE Healthcare’s technology prowess to answer fundamental questions in biology and medicine.  ... Read more

GE Healthcare Acquires Leading Healthcare Advisory Firm, The Camden Group, to enable Healthcare Organizations to Navigate Industry Transformation

BARRINGTON, Ill., November 9, 2015 — GE Healthcare (NYSE: GE) announced today it is expanding its U.S. healthcare consulting business with the acquisition of The Camden Group, one of the nation’s leading population health & strategic advisory firms. GE Healthcare Camden Group will act as the U.S. business unit of GE Healthcare’s global advisory firm,... Read more